KOL Data

Sales & Marketing

As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.

Partner Content

how to navigate through KOL insights & management

News

Novartis shares have slipped after it revealed its Lp(a)-targeted drug, pelacarsen, failed to reduce cardiovascular risks in a major phase 3 trial.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.